Enqi Qiao

652 total citations
25 papers, 475 citations indexed

About

Enqi Qiao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Enqi Qiao has authored 25 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Enqi Qiao's work include Nanoplatforms for cancer theranostics (6 papers), MicroRNA in disease regulation (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Enqi Qiao is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), MicroRNA in disease regulation (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Enqi Qiao collaborates with scholars based in China. Enqi Qiao's co-authors include Jian Wu, Minghua Ji, Hongjian Yang, Gaofeng Shu, Shiji Fang, Yongzhong Du, Jiansong Ji, Minjiang Chen, Qinglin Li and Liang Xia and has published in prestigious journals such as Biomaterials, ACS Applied Materials & Interfaces and Human Molecular Genetics.

In The Last Decade

Enqi Qiao

25 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enqi Qiao China 14 203 146 99 93 64 25 475
Chang‐Chun Ling China 12 235 1.2× 96 0.7× 108 1.1× 66 0.7× 42 0.7× 24 530
Michelle Boisdron-Celle France 7 114 0.6× 44 0.3× 33 0.3× 144 1.5× 50 0.8× 9 364
Yanwen Zheng China 13 209 1.0× 104 0.7× 58 0.6× 74 0.8× 103 1.6× 27 425
Hui-Yen Chuang Taiwan 11 246 1.2× 159 1.1× 79 0.8× 124 1.3× 48 0.8× 18 466
Melissa Loren United States 6 245 1.2× 106 0.7× 84 0.8× 98 1.1× 57 0.9× 6 449
Daniel J. Smit Germany 13 286 1.4× 179 1.2× 65 0.7× 283 3.0× 72 1.1× 41 609
Austin J. Combest United States 9 213 1.0× 92 0.6× 57 0.6× 290 3.1× 198 3.1× 19 565
Chloé Sauzay France 12 329 1.6× 204 1.4× 45 0.5× 150 1.6× 160 2.5× 19 671
Julia Kirshner United States 15 368 1.8× 97 0.7× 63 0.6× 379 4.1× 75 1.2× 30 848
Murali K. Ravoori United States 12 455 2.2× 204 1.4× 63 0.6× 198 2.1× 87 1.4× 20 734

Countries citing papers authored by Enqi Qiao

Since Specialization
Citations

This map shows the geographic impact of Enqi Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enqi Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enqi Qiao more than expected).

Fields of papers citing papers by Enqi Qiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enqi Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enqi Qiao. The network helps show where Enqi Qiao may publish in the future.

Co-authorship network of co-authors of Enqi Qiao

This figure shows the co-authorship network connecting the top 25 collaborators of Enqi Qiao. A scholar is included among the top collaborators of Enqi Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enqi Qiao. Enqi Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Xin, Enqi Qiao, Gao‐Jun Teng, & Fei Xiong. (2025). Quaternary ammonium salt microspheres loaded with vascular disrupting agents for targeted interventional therapy of hepatocellular carcinoma. Acta Biomaterialia. 203. 591–603. 2 indexed citations
2.
Qiao, Enqi, Jiayi Ding, Xiaoxiao Chen, et al.. (2025). Biomaterial-mediated modulation of tumor microenvironment and therapeutic sensitization. 2(4). 100092–100092. 1 indexed citations
3.
Qiao, Enqi, et al.. (2024). An endoplasmic reticulum stress related signature for clinically predicting prognosis of breast cancer patients. Human Molecular Genetics. 1 indexed citations
4.
Chen, Mingzhen, Chunli Kong, Enqi Qiao, et al.. (2023). Multi-algorithms analysis for pre-treatment prediction of response to transarterial chemoembolization in hepatocellular carcinoma on multiphase MRI. Insights into Imaging. 14(1). 38–38. 14 indexed citations
5.
Zhang, Nannan, Gaofeng Shu, Enqi Qiao, et al.. (2022). DNA-Functionalized Liposomes In Vivo Fusion for NIR-II/MRI Guided Pretargeted Ferroptosis Therapy of Metastatic Breast Cancer. ACS Applied Materials & Interfaces. 14(18). 20603–20615. 17 indexed citations
6.
Chen, Minjiang, Gaofeng Shu, Xiuling Lv, et al.. (2022). HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma. Biomaterials. 284. 121512–121512. 45 indexed citations
7.
Chen, Weiqian, Yanping Su, Junchao Yu, et al.. (2022). Integrated application of transcriptome and metabolomics reveals potential therapeutic targets for the polarization of atherosclerotic macrophages. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(12). 166550–166550. 13 indexed citations
8.
Chen, Minjiang, Jie Li, Gaofeng Shu, et al.. (2022). Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization. Journal of Nanobiotechnology. 20(1). 179–179. 34 indexed citations
9.
Shu, Gaofeng, Jiayi Ding, Xiaoxiao Chen, et al.. (2022). Fucoidan-based dual-targeting mesoporous polydopamine for enhanced MRI-guided chemo-photothermal therapy of HCC via P-selectin-mediated drug delivery. Asian Journal of Pharmaceutical Sciences. 17(6). 908–923. 16 indexed citations
10.
Qiao, Enqi, et al.. (2021). Curcuma zedoaria petroleum ether extract reverses the resistance of triple-negative breast cancer to docetaxel via pregnane X receptor. Annals of Translational Medicine. 9(17). 1389–1389. 3 indexed citations
11.
12.
Qiao, Enqi, Hongjian Yang, & Xiping Zhang. (2020). Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis. Journal of Zhejiang University SCIENCE B. 21(6). 495–508. 4 indexed citations
13.
Qiao, Enqi, Xingfei Yu, Lingyan Zhou, et al.. (2019). A Prospective Validation Cohort Study of a Prediction Model on Non-sentinel Lymph Node Involvement in Early Breast Cancer. Annals of Surgical Oncology. 27(5). 1653–1658. 5 indexed citations
14.
Zhang, Xiping, et al.. (2018). Research Progresses in Cancer Stem Cells of Three Common Fertility-Related Female Malignancies. Pathology & Oncology Research. 25(3). 827–835. 1 indexed citations
15.
Wang, Chen, Xianghou Xia, Feng Chen, et al.. (2017). ICT1 knockdown inhibits breast cancer cell growth via induction of cell cycle arrest and apoptosis. International Journal of Molecular Medicine. 39(4). 1037–1045. 11 indexed citations
16.
Xia, Liang, Caixing Sun, Qinglin Li, et al.. (2015). CELF1 is Up-Regulated in Glioma and Promotes Glioma Cell Proliferation by Suppression of CDKN1B. International Journal of Biological Sciences. 11(11). 1314–1324. 21 indexed citations
17.
Qiao, Enqi & Hongjian Yang. (2014). Effect of pregnane X receptor expression on drug resistance in breast cancer. Oncology Letters. 7(4). 1191–1196. 23 indexed citations
18.
Wu, Jian, Minghua Ji, Tao Ma, et al.. (2013). miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer. Experimental and Therapeutic Medicine. 5(3). 813–818. 59 indexed citations
19.
Qiao, Enqi, Minghua Ji, Jian Wu, et al.. (2013). Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer. Molecular and Clinical Oncology. 1(4). 703–710. 11 indexed citations
20.
Qiao, Enqi, Minghua Ji, Jian Wu, et al.. (2013). Expression of the PXR gene in various types of cancer and drug resistance. Oncology Letters. 5(4). 1093–1100. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang‐Chun Ling Breakdown of academic impact, for papers by Michelle Boisdron-Celle Breakdown of academic impact, for papers by Yanwen Zheng Breakdown of academic impact, for papers by Hui-Yen Chuang Breakdown of academic impact, for papers by Melissa Loren Breakdown of academic impact, for papers by Daniel J. Smit Breakdown of academic impact, for papers by Austin J. Combest Breakdown of academic impact, for papers by Chloé Sauzay Breakdown of academic impact, for papers by Julia Kirshner Breakdown of academic impact, for papers by Murali K. Ravoori
Rankless by CCL
2026